Ajanta Pharma Limited has informed the Exchange about General Updates

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.9%1-day move

₹2900.00

prior close

₹2958.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.6+0.6+1.6+5.9+4.6+5.2+6.4+7.8+9.6+4.3+2.4+16.4—

Up moveDown movePending

AI summary

Ajanta Pharma's Nomination and Remuneration Committee has granted 145,000 stock options to employees under the Ajanta Pharma Share Based Incentive Plan 2019. Each option entitles the holder to one share, with an exercise period of three months from the date of vesting. Additionally, the committee approved the cancellation of 850 stock options, which have been credited back to the ESOP pool. The disclosure was made under SEBI's Regulation 30 of the Listing Obligations and Disclosure Requirements Regulations, 2015.

Likely market impact

The ESOP grant of 145,000 options represents a routine employee compensation exercise with minimal potential dilution given the company's larger share base. The cancellation of 850 options has a negligible impact. This is standard corporate governance disclosure with neutral implications for shareholders.